CLRPF
Price
$2.85
Change
-$0.32 (-10.09%)
Updated
Aug 7 closing price
Capitalization
1.05B
DOSEF
Price
$1.02
Change
-$0.00 (-0.00%)
Updated
Jul 21 closing price
Capitalization
2.94M
Interact to see
Advertisement

CLRPF vs DOSEF

Header iconCLRPF vs DOSEF Comparison
Open Charts CLRPF vs DOSEFBanner chart's image
Clarity Pharmaceuticals
Price$2.85
Change-$0.32 (-10.09%)
Volume$6.87K
Capitalization1.05B
Doseology Sciences
Price$1.02
Change-$0.00 (-0.00%)
Volume$2.18K
Capitalization2.94M
CLRPF vs DOSEF Comparison Chart in %
Loading...
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRPF vs. DOSEF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRPF is a Hold and DOSEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CLRPF: $2.85 vs. DOSEF: $1.04)
Brand notoriety: CLRPF and DOSEF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRPF: 89% vs. DOSEF: 13%
Market capitalization -- CLRPF: $1.05B vs. DOSEF: $2.94M
CLRPF [@Biotechnology] is valued at $1.05B. DOSEF’s [@Biotechnology] market capitalization is $2.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRPF’s FA Score shows that 0 FA rating(s) are green whileDOSEF’s FA Score has 0 green FA rating(s).

  • CLRPF’s FA Score: 0 green, 5 red.
  • DOSEF’s FA Score: 0 green, 5 red.
According to our system of comparison, DOSEF is a better buy in the long-term than CLRPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRPF’s TA Score shows that 3 TA indicator(s) are bullish while DOSEF’s TA Score has 3 bullish TA indicator(s).

  • CLRPF’s TA Score: 3 bullish, 3 bearish.
  • DOSEF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, DOSEF is a better buy in the short-term than CLRPF.

Price Growth

CLRPF (@Biotechnology) experienced а +0.18% price change this week, while DOSEF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLRPF($1.05B) has a higher market cap than DOSEF($2.94M). DOSEF YTD gains are higher at: 640.214 vs. CLRPF (5.360). DOSEF has higher annual earnings (EBITDA): -296.52K vs. CLRPF (-66.98M).
CLRPFDOSEFCLRPF / DOSEF
Capitalization1.05B2.94M35,838%
EBITDA-66.98M-296.52K22,590%
Gain YTD5.360640.2141%
P/E RatioN/AN/A-
RevenueN/A46.7K-
Total CashN/A820K-
Total DebtN/A0-
TECHNICAL ANALYSIS
Technical Analysis
CLRPFDOSEF
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
55%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
58%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
52%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
55%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 22 days ago
90%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 3 days ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASMB21.222.36
+12.51%
Assembly Biosciences
TXNM57.100.04
+0.07%
TXNM Energy Inc
TEF5.36-0.03
-0.56%
Telefonica SA
OPTT0.51-0.01
-0.99%
Ocean Power Technologies
EVLV6.98-0.14
-1.97%
Evolv Technologies Holdings

CLRPF and

Correlation & Price change

A.I.dvisor tells us that CLRPF and SBHMY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRPF and SBHMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRPF
1D Price
Change %
CLRPF100%
-10.09%
SBHMY - CLRPF
24%
Poorly correlated
N/A
BOLD - CLRPF
23%
Poorly correlated
-3.39%
AKBA - CLRPF
21%
Poorly correlated
-20.48%
DOSEF - CLRPF
12%
Poorly correlated
N/A
ACUT - CLRPF
9%
Poorly correlated
+4.37%
More

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and MNPR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
N/A
MNPR - DOSEF
24%
Poorly correlated
-1.35%
AKRO - DOSEF
23%
Poorly correlated
-4.43%
SGMT - DOSEF
21%
Poorly correlated
+1.00%
ADAG - DOSEF
21%
Poorly correlated
-8.02%
CLRPF - DOSEF
12%
Poorly correlated
-10.09%
More